# IGSF1

## Overview
The IGSF1 gene encodes the immunoglobulin superfamily member 1, a transmembrane glycoprotein that is part of the immunoglobulin superfamily. This protein is characterized by its complex structure, which includes multiple immunoglobulin-like domains, and plays a significant role in the regulation of hormone expression within the pituitary gland. IGSF1 is primarily expressed in thyrotropes and gonadotropes, where it modulates key signaling pathways such as TGFβ and activin, influencing the synthesis of thyroid-stimulating hormone (TSH) and follicle-stimulating hormone (FSH) (García2017The). Mutations in the IGSF1 gene can lead to IGSF1 deficiency syndrome, an X-linked disorder characterized by central hypothyroidism and macroorchidism, among other endocrine abnormalities (Joustra2013IGSF1; TenenbaumRakover2016Familial). The protein's interactions with signaling pathways underscore its critical role in maintaining endocrine function and its potential impact on reproductive health (Bernard2020A).

## Structure
The IGSF1 protein is a transmembrane glycoprotein that is part of the immunoglobulin superfamily, characterized by its complex molecular structure. It consists of 1327 amino acids and includes 12 C2-type immunoglobulin-like domains, which are typical of the immunoglobulin superfamily and contain conserved cysteine residues forming intradomain disulfide bonds (Smith2022The; Mazzarella1998Cloning). These domains are organized into a sandwich of two beta-sheets stabilized by these disulfide bonds, suggesting a role in cell surface recognition or cell-cell interaction (Mazzarella1998Cloning).

The protein undergoes co-translational cleavage in the endoplasmic reticulum, resulting in two main domains: the N-terminal domain (NTD) and the C-terminal domain (CTD). The NTD contains five Ig loops, while the CTD contains seven Ig loops, with the CTD being more highly conserved and considered the functional part of the molecule (Smith2022The). The CTD is trafficked to the plasma membrane, and its proper trafficking is crucial for the protein's function, as mutations often inhibit this process (Joustra2015Spatial).

IGSF1 is associated with multiple mRNA isoforms, with the full-length protein encoded by isoform 1, while isoform 4 encodes only the CTD (Smith2022The). The protein is also related to the leukocyte receptor cluster (LRC) family, sharing ancestry with proteins like alpha-1-B glycoprotein (A1BG) (Smith2022The).

## Function
The IGSF1 gene encodes a transmembrane glycoprotein that plays a crucial role in the regulation of hormone expression in the pituitary gland. It is primarily expressed in thyrotropes and gonadotropes, which are responsible for producing thyroid-stimulating hormone (TSH) and follicle-stimulating hormone (FSH), respectively (García2017The). IGSF1 modulates the TGFβ and activin signaling pathways, which are essential for maintaining the balance of hormone production. It stimulates the thyrotropin-releasing hormone receptor (TRHR) promoter, enhancing TSH synthesis, while repressing the FSHB promoter, thereby reducing FSH expression (García2017The).

In healthy cells, IGSF1 prevents the TGFβ1-induced down-regulation of TRHR expression, which is vital for proper TSH secretion signaling (García2017The). The gene's expression is enriched in gonadotrope and thyrotrope cells of the pituitary, but not in somatotrope cells, indicating a cell-specific expression pattern (García2017The). IGSF1 is also expressed in the testes, particularly in germ cells and Leydig cells, suggesting a role in reproductive function (García2017The). The protein's function is critical for normal endocrine function, and its deficiency can lead to conditions such as central hypothyroidism and macroorchidism (García2017The).

## Clinical Significance
Mutations in the IGSF1 gene are associated with IGSF1 deficiency syndrome, an X-linked endocrinopathy characterized by central hypothyroidism and macroorchidism. This condition results from loss-of-function mutations or deletions in the IGSF1 gene, leading to a deficiency in thyroid-stimulating hormone (TSH) and affecting normal hormonal regulation (Joustra2013IGSF1; TenenbaumRakover2016Familial). Affected males often exhibit prolactin deficiency, partial and transient growth hormone deficiency, and disharmonious pubertal development. Some may also experience overweight and increased body mass index (Joustra2013IGSF1; TenenbaumRakover2016Familial).

The syndrome is marked by delayed testosterone secretion and pubertal development, resembling a constitutional delay of growth and puberty (Joustra2013IGSF1). In some cases, mutations in IGSF1 can lead to neurological phenotypes such as hypotonia, delayed psychomotor development, and attention deficit disorder (TenenbaumRakover2016Familial). Female carriers may experience mild central hypothyroidism due to skewed X inactivation (Persani2017The).

IGSF1 mutations can also result in variable prolactin and growth hormone deficiencies, with some individuals not requiring lifelong supplemental therapy (TenenbaumRakover2016Familial). The gene's role in regulating TGFβ/Activin pathways in the pituitary contributes to the phenotypic variability observed in patients (García2017The).

## Interactions
IGSF1 interacts with components of the TGFβ and Activin signaling pathways, influencing gene expression in the pituitary gland. It represses the activity of the FSHB promoter and stimulates the TRHR promoter, modulating the TGFβ signaling pathway by reducing the phosphorylation of SMAD2, a key component of this pathway (García2017The). IGSF1 also interacts with the Activin type I receptor, ALK4, inhibiting its activity independently of inhibins, which suggests a role in modulating Activin signaling (Bernard2020A). 

IGSF1's interaction with the Activin-Smad pathway involves a potent inhibitory effect on the CAGA promoter, a surrogate for the FSHB promoter, through the ALK4 receptor (García2017The). Although IGSF1 was initially thought to act as a receptor for inhibin B, direct binding between IGSF1 and inhibin B has not been demonstrated (García2017The). The protein's regulatory effects on gene promoters suggest interactions with transcriptional machinery and signaling pathways, although specific physical interactions with other proteins or nucleic acids are not detailed in the available studies (García2017The).


## References


[1. (Persani2017The) Luca Persani and Marco Bonomi. The multiple genetic causes of central hypothyroidism. Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism, 31(2):255–263, March 2017. URL: http://dx.doi.org/10.1016/j.beem.2017.04.003, doi:10.1016/j.beem.2017.04.003. This article has 30 citations.](https://doi.org/10.1016/j.beem.2017.04.003)

[2. (Mazzarella1998Cloning) Richard Mazzarella, Gina Pengue, Jonathan Jones, Carmela Jones, and David Schlessinger. Cloning and expression of an immunoglobulin superfamily gene (igsf1) in xq25. Genomics, 48(2):157–162, March 1998. URL: http://dx.doi.org/10.1006/GENO.1997.5156, doi:10.1006/geno.1997.5156. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.1997.5156)

[3. (Bernard2020A) Daniel J. Bernard, Courtney L. Smith, and Emilie Brûlé. A tale of two proteins: betaglycan, igsf1, and the continuing search for the inhibin b receptor. Trends in Endocrinology &amp; Metabolism, 31(1):37–45, January 2020. URL: http://dx.doi.org/10.1016/j.tem.2019.08.014, doi:10.1016/j.tem.2019.08.014. This article has 17 citations.](https://doi.org/10.1016/j.tem.2019.08.014)

[4. (Joustra2013IGSF1) Sjoerd D. Joustra, A. S. Paul van Trotsenburg, Yu Sun, Monique Losekoot, Daniel J. Bernard, Nienke R. Biermasz, Wilma Oostdijk, and Jan M. Wit. Igsf1 deficiency syndrome: a newly uncovered endocrinopathy. Rare Diseases, 1(1):e24883, January 2013. URL: http://dx.doi.org/10.4161/rdis.24883, doi:10.4161/rdis.24883. This article has 24 citations.](https://doi.org/10.4161/rdis.24883)

[5. (Smith2022The) Courtney L. Smith, Paul M. Harrison, and Daniel J. Bernard. The extant immunoglobulin superfamily, member 1 gene results from an ancestral gene duplication in eutherian mammals. PLOS ONE, 17(6):e0267744, June 2022. URL: http://dx.doi.org/10.1371/journal.pone.0267744, doi:10.1371/journal.pone.0267744. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0267744)

[6. (Joustra2015Spatial) Sjoerd D Joustra, Onno C Meijer, Charlotte A Heinen, Isabel M Mol, El Houari Laghmani, Rozemarijn M A Sengers, Gabriela Carreno, A S Paul van Trotsenburg, Nienke R Biermasz, Daniel J Bernard, Jan M Wit, Wilma Oostdijk, Ans M M van Pelt, Geert Hamer, and Gerry T M Wagenaar. Spatial and temporal expression of immunoglobulin superfamily member 1 in the rat. Journal of Endocrinology, 226(3):181–191, July 2015. URL: http://dx.doi.org/10.1530/joe-15-0204, doi:10.1530/joe-15-0204. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1530/joe-15-0204)

[7. (TenenbaumRakover2016Familial) Yardena Tenenbaum-Rakover, Marc-Olivier Turgeon, Shira London, Pia Hermanns, Joachim Pohlenz, Daniel J. Bernard, and Dani Bercovich. Familial central hypothyroidism caused by a novel igsf1 gene mutation. Thyroid, 26(12):1693–1700, December 2016. URL: http://dx.doi.org/10.1089/thy.2015.0672, doi:10.1089/thy.2015.0672. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/thy.2015.0672)

[8. (García2017The) Marta García, Raquel Barrio, Montserrat García-Lavandeira, Angela R. Garcia-Rendueles, Adela Escudero, Esther Díaz-Rodríguez, Darya Gorbenko Del Blanco, Ana Fernández, Yolanda B. de Rijke, Elena Vallespín, Julián Nevado, Pablo Lapunzina, Vilborg Matre, Patricia M. Hinkle, Anita C. S. Hokken-Koelega, María P. de Miguel, José Manuel Cameselle-Teijeiro, Manuel Nistal, Clara V. Alvarez, and José C. Moreno. The syndrome of central hypothyroidism and macroorchidism: igsf1 controls trhr and fshb expression by differential modulation of pituitary tgfβ and activin pathways. Scientific Reports, March 2017. URL: http://dx.doi.org/10.1038/srep42937, doi:10.1038/srep42937. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep42937)